Armstrong Teasdale served as IP counsel to LAVA Therapeutics, while Ballard Spahr served as counsel on additional terms. Seagen Inc. (Nasdaq: SGEN), a world leader and...
LAVA Therapeutics’ License Agreement with Seagen, Inc.
LAVA Therapeutics’ Nasdaq IPO
NautaDutilh assisted LAVA Therapeutics B.V. on the deal. LAVA Therapeutics B.V. (Nasdaq: LVTX) closed its IPO on the Nasdaq Global Market, raising approximately USD 100 million...